Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2010
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874024A 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
10/27/2010CN101869683A Chinese medicinal composition for treating dry cough
10/27/2010CN101869682A Traditional Chinese medicine for treating cold cough
10/27/2010CN101869678A Medicament for treating bronchitis cough
10/27/2010CN101869672A Moxibustion liquid and preparation process thereof
10/27/2010CN101869664A Platypharodon medicine transfusion paste preparation for preventing and treating upper respiratory tract diseases and preparation method thereof
10/27/2010CN101869662A Chinese medicinal preparation for treating chronic pharyngitis
10/27/2010CN101869658A Chinese medicinal infusion tea for treating chronic pharyngitis and preparation method thereof
10/27/2010CN101869657A Plaster used together with cigarettes, method for preparing same and ring containing same
10/27/2010CN101869656A Chinese medicinal preparation for treating cough with asthma and preparation method thereof
10/27/2010CN101869653A Chinese medicinal preparation for treating chronic nasosinusitis and preparation method thereof
10/27/2010CN101869617A Traditional Chinese medicine for treating cough
10/27/2010CN101869612A Maxingshigan oral liquid and preparation method thereof
10/27/2010CN101869595A Preparation method and quality detection method of liquorice and gall oral liquid
10/27/2010CN101869593A Detection method of pill capable of dissipating phlegm and stopping coughing
10/27/2010CN101869570A Ciclesonide contained pharmaceutical composition for application to mucosa
10/27/2010CN101869568A Use of autophagy (B-cell apoptosis) inhibitor
10/27/2010CN101869544A Ambroxol hydrochloride controlled release suspension and preparation method thereof
10/27/2010CN101869165A Styrax faberi Perk leaf tea and preparation method thereof
10/27/2010CN101708249B Buccal tablets used for treating wind-heat acute pharyngitis
10/27/2010CN101361786B Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides
10/27/2010CN101279092B Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/27/2010CN101229172B Solid dispersing agent of glycyrrhetinic acid 30-acylamide derivatives, preparing method and uses thereof
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820694 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
10/26/2010US7820687 inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, diabetes, autoimmune diseases, tumor metastasis and myocardial ischemia; improved bioavailability; 2-(2-(diethylamino)-5-(N-isopropylmethylsulfonamido)pyrimidin-4-ylamino)-3-(4-(pyrrolidine-1-carbonyloxy)phenyl)propanoic acid
10/26/2010US7820644 Substituted porphyrins
10/26/2010US7820199 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2304700C Lipophilic diesters of chelating agents
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010120566A2 METHODS FOR TREATING IgE-MEDIATED DISORDER
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119819A1 Method of preparing human lung tissue stem cells and method of inducing differentiation into human alveolar epithelial cells
10/21/2010WO2010118852A1 ( pyrazol-3-yl) -1, 3, 4-thiadiazol-2-amine and ( pyrazol-3-yl) -1, 3, 4-thiazol-2-amine compounds
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010065843A3 Biologic scaffold for prevention of pulmonary fibrosis
10/21/2010US20100267833 Compositions and methods for preventing or treating an inflammatory response
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267774 P38 map kinase inhibitors
10/21/2010US20100267769 Substituted Bicyclocarboxyamide Compounds
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267763 Method of Decreasing Pro-ADAM10 Secretase and/or Beta Secretase Levels
10/21/2010US20100267749 Trisubstituted furopyrimidines and use thereof
10/21/2010US20100267746 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
10/21/2010US20100267728 3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267718 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267616 Acute respiratory syndromes
10/21/2010US20100267615 Methods for treatment and/or prevention of a disease associated with vascular leak
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100266697 Mixed ligand surface-modified nanoparticles
10/21/2010US20100266696 Organic Compounds
10/21/2010US20100266668 Manufacturing Dissolvable Dosage Forms
10/21/2010US20100266643 Pulmonary and nasal delivery of serum amyloid p
10/21/2010US20100266614 Ultra high affinity neutralizing antibodies
10/21/2010US20100266594 Il-9 in fibrotic and inflammatory disease
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266573 Method and means for obtaining bronchorelaxation
10/21/2010US20100266552 Treatment of chronic lung disease
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2758245A1 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2241315A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
10/20/2010EP2240469A2 Substantially pure and a stable crystalline form of bosentan
10/20/2010EP2240444A1 Compounds having crth2 antagonist activity
10/20/2010EP2114945B1 Pteridinone derivatives as pi3-kinases inhibitors
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1383513B1 Tumor therapy with sindbis virus-based vectors
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010CN101868242A Method and means for obtaining bronchorelaxation
10/20/2010CN101862449A Compositions and methods for treatment of candidiasis
10/20/2010CN101862442A Cough-relieving Chinese medicinal composition and preparation method thereof
10/20/2010CN101862439A Anti-inflammatory throat lozenge containing natural Zingiber corallinum Hance essential oil
10/20/2010CN101862437A Chinese medicinal composition for treating asthma
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 878